Ironwood Pharmaceuticals, Inc.
IRWD
$4.31
$0.235.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.80% | 1,891.43% | -105.68% | 69.84% | 163.12% |
| Total Depreciation and Amortization | 3.16% | -3.70% | -3.16% | 1.71% | -2.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.81% | 710.11% | -90.92% | 64.90% | 188.06% |
| Change in Net Operating Assets | 78.73% | -181.41% | 391.44% | 57.04% | -217.19% |
| Cash from Operations | 1,037.98% | -93.13% | 56.73% | 415.79% | -175.51% |
| Capital Expenditure | -- | -- | 150.00% | 0.00% | 93.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 150.00% | 0.00% | 93.55% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | 1,366.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | 1,366.67% |
| Foreign Exchange rate Adjustments | 172.64% | -130.20% | 1,450.00% | 95.98% | -9,142.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,918.42% | -93.32% | 57.82% | 404.27% | -178.45% |